These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 17433707)
1. Role of caveolins in body weight and insulin resistance regulation. Frühbeck G; López M; Diéguez C Trends Endocrinol Metab; 2007 Jul; 18(5):177-82. PubMed ID: 17433707 [TBL] [Abstract][Full Text] [Related]
2. The biology of caveolae: lessons from caveolin knockout mice and implications for human disease. Hnasko R; Lisanti MP Mol Interv; 2003 Dec; 3(8):445-64. PubMed ID: 14993453 [TBL] [Abstract][Full Text] [Related]
3. Cholesterol-induced caveolin targeting to lipid droplets in adipocytes: a role for caveolar endocytosis. Le Lay S; Hajduch E; Lindsay MR; Le Lièpvre X; Thiele C; Ferré P; Parton RG; Kurzchalia T; Simons K; Dugail I Traffic; 2006 May; 7(5):549-61. PubMed ID: 16643278 [TBL] [Abstract][Full Text] [Related]
4. Regulation of insulin response in skeletal muscle cell by caveolin status. Oh YS; Cho KA; Ryu SJ; Khil LY; Jun HS; Yoon JW; Park SC J Cell Biochem; 2006 Oct; 99(3):747-58. PubMed ID: 16676355 [TBL] [Abstract][Full Text] [Related]
5. Time-dependent regulation of muscle caveolin activation and insulin signalling in response to high-fat diet. Gómez-Ruiz A; de Miguel C; Campión J; Martínez JA; Milagro FI FEBS Lett; 2009 Oct; 583(19):3259-64. PubMed ID: 19751730 [TBL] [Abstract][Full Text] [Related]
6. Plasma membrane cyclic nucleotide phosphodiesterase 3B (PDE3B) is associated with caveolae in primary adipocytes. Nilsson R; Ahmad F; Swärd K; Andersson U; Weston M; Manganiello V; Degerman E Cell Signal; 2006 Oct; 18(10):1713-21. PubMed ID: 16503395 [TBL] [Abstract][Full Text] [Related]
7. Role of caveolin and caveolae in insulin signaling and diabetes. Cohen AW; Combs TP; Scherer PE; Lisanti MP Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1151-60. PubMed ID: 14607781 [TBL] [Abstract][Full Text] [Related]
8. Caveolae and caveolin in transmembrane signaling: Implications for human disease. Schwencke C; Braun-Dullaeus RC; Wunderlich C; Strasser RH Cardiovasc Res; 2006 Apr; 70(1):42-9. PubMed ID: 16412403 [TBL] [Abstract][Full Text] [Related]
9. Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. Razani B; Combs TP; Wang XB; Frank PG; Park DS; Russell RG; Li M; Tang B; Jelicks LA; Scherer PE; Lisanti MP J Biol Chem; 2002 Mar; 277(10):8635-47. PubMed ID: 11739396 [TBL] [Abstract][Full Text] [Related]
10. Caveolae and endothelial dysfunction: filling the caves in cardiovascular disease. Xu Y; Buikema H; van Gilst WH; Henning RH Eur J Pharmacol; 2008 May; 585(2-3):256-60. PubMed ID: 18423600 [TBL] [Abstract][Full Text] [Related]
11. Caveolin-1 interacts and cooperates with the transforming growth factor-beta type I receptor ALK1 in endothelial caveolae. Santibanez JF; Blanco FJ; Garrido-Martin EM; Sanz-Rodriguez F; del Pozo MA; Bernabeu C Cardiovasc Res; 2008 Mar; 77(4):791-9. PubMed ID: 18065769 [TBL] [Abstract][Full Text] [Related]
12. Role of caveolae and caveolins in health and disease. Cohen AW; Hnasko R; Schubert W; Lisanti MP Physiol Rev; 2004 Oct; 84(4):1341-79. PubMed ID: 15383654 [TBL] [Abstract][Full Text] [Related]
13. Cell biology. Life without caveolae. Parton RG Science; 2001 Sep; 293(5539):2404-5. PubMed ID: 11577223 [No Abstract] [Full Text] [Related]
14. The association of caveolae, actin, and the dystrophin-glycoprotein complex: a role in smooth muscle phenotype and function? Halayko AJ; Stelmack GL Can J Physiol Pharmacol; 2005 Oct; 83(10):877-91. PubMed ID: 16333360 [TBL] [Abstract][Full Text] [Related]
15. Getting rid of caveolins: phenotypes of caveolin-deficient animals. Le Lay S; Kurzchalia TV Biochim Biophys Acta; 2005 Dec; 1746(3):322-33. PubMed ID: 16019085 [TBL] [Abstract][Full Text] [Related]
16. Evolutionary analysis and molecular dissection of caveola biogenesis. Kirkham M; Nixon SJ; Howes MT; Abi-Rached L; Wakeham DE; Hanzal-Bayer M; Ferguson C; Hill MM; Fernandez-Rojo M; Brown DA; Hancock JF; Brodsky FM; Parton RG J Cell Sci; 2008 Jun; 121(Pt 12):2075-86. PubMed ID: 18505796 [TBL] [Abstract][Full Text] [Related]
18. Targeting of PKCzeta and PKB to caveolin-enriched microdomains represents a crucial step underpinning the disruption in PKB-directed signalling by ceramide. Hajduch E; Turban S; Le Liepvre X; Le Lay S; Lipina C; Dimopoulos N; Dugail I; Hundal HS Biochem J; 2008 Mar; 410(2):369-79. PubMed ID: 17983354 [TBL] [Abstract][Full Text] [Related]
19. Raft association and lipid droplet targeting of flotillins are independent of caveolin. Rajendran L; Le Lay S; Illges H Biol Chem; 2007 Mar; 388(3):307-14. PubMed ID: 17338638 [TBL] [Abstract][Full Text] [Related]
20. Caveolin-1 as a potential new therapeutic target in multiple myeloma. Podar K; Anderson KC Cancer Lett; 2006 Feb; 233(1):10-5. PubMed ID: 16473666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]